NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Warm Wishes for the Holiday Season from Countryside Neurology
🎄✨ Wishing you and your loved ones a season filled with joy, kindness, and togetherness. Happy Holidays from the Countryside [...]
Innovative TMS Therapy for Cognitive Enhancement in Age-Related Cognitive Decline: A Promising Study
Introduction: A recent study, published in the Annals of Clinical Psychiatry, explores the effectiveness of Transcranial Magnetic Stimulation (TMS) in [...]
Unlock Happiness: Experience Fast-Acting TMS Treatments
Introduction: At Countryside Neurology, we're dedicated to staying at the forefront of innovative neurological treatments. Transcranial Magnetic Stimulation (TMS), recognized [...]
Enhancing Aphasia Recovery After Stroke: Insights from Theta Burst Stimulation
Introduction: Aphasia, the impairment of language ability, frequently follows a stroke, making communication challenging and often frustrating for both survivors [...]
Enhancing Pain Relief in Postherpetic Neuralgia: A Comparison of rTMS Frequencies
Background: Postherpetic neuralgia (PHN) is a painful and often challenging condition to manage. A recent study found online suggests that [...]
Enhancing Cognitive Function After Stroke: The Impact of iTBS
Introduction: In this article, published in June 2022, we delve into a recent study that explores a promising approach for [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social